Hexagon Nutrition IPO

UpcomingMainboard

Price Band

42 – ₹45

Issue Size

138.87 Cr

Lot Size

333 shares

Min ₹14,985

Issue Dates

5 Jun 9 Jun 2026

Listing Date

12 Jun 2026

About Hexagon Nutrition Ltd.

Hexagon Nutrition Ltd. is a research-driven nutrition company focused on improving health outcomes through scientifically formulated nutrition products. Incorporated in 1993, the company has built strong capabilities in the development and manufacturing of micronutrient premixes, clinical nutrition solutions, therapeutic formulations, and ready-to-use foods. It operates at the intersection of healthcare, wellness, and food technology, addressing nutritional deficiencies and supporting preventive healthcare across diverse population segments. The company’s product portfolio is broadly divided into three segments: branded wellness and clinical nutrition (B2C), premix formulations (B2B/B2B2C), and ready-to-use foods and micronutrient powders. Its B2C segment includes products such as protein supplements, pediatric nutrition, weight management solutions, and disease-specific formulations sold under brands like Pentasure, Obesigo, Pediagold, and Nutrone. These products are widely distributed through pharmacies, hospitals, online platforms, and its own digital channels, enabling broad accessibility to consumers. In the B2B and B2B2C segments, Hexagon Nutrition collaborates with food and pharmaceutical companies by supplying customized micronutrient premixes and fortification solutions. These premixes are essential for enhancing the nutritional value of staple foods and processed products. The company also plays a significant role in public health and ESG initiatives through its Ready-to-Use Foods (RUFs) and Micronutrient Powders (MNPs), which are designed to combat malnutrition, particularly in developing regions. Hexagon Nutrition operates a well-established manufacturing infrastructure with facilities located in Nasik, Chennai, and Thoothukudi in India, along with an international manufacturing unit in Tashkent, Uzbekistan. The facilities in Chennai and Thoothukudi are located in Special Economic Zones (SEZs), offering advantages such as proximity to ports and duty benefits on imports and exports. This strategic manufacturing footprint enables efficient production, cost optimization, and seamless supply chain operations for both domestic and global markets. The company has a strong global presence, exporting its products to over 75 countries across Asia, Africa, Europe, and South America. It has set up international offices in South Africa, Uzbekistan, and Hong Kong to strengthen its export operations and global partnerships. Domestically, the company has developed an extensive distribution network comprising over 350 distributors, including several with multi-state presence, ensuring deep market penetration across India. A key strength of Hexagon Nutrition lies in its dedicated focus on research and development. The company operates in-house R&D facilities in Nasik and Chennai, supported by a team of qualified professionals specializing in nutrition science and formulation development. This emphasis on innovation enables the company to continuously introduce new products, adapt to evolving consumer needs, and maintain compliance with international quality standards, positioning it as a competitive player in the global nutrition and healthcare industry.

Visit Website

IPO Details

Price Band₹42 – ₹45
Face Value₹1
Lot Size333 shares(Min ₹14,985)
Issue Size₹138.87 Cr
Fresh IssueTBA
Offer for Sale138.87 Cr
Total Shares Offered3,08,59,704
Listed OnBoth

Objects of the Issue

The IPO is entirely an Offer for Sale (OFS). The company will not receive any proceeds from the issue. All proceeds will go to the selling shareholders.

Key Financial Metrics

EPS (Basic)

2.93

P/E Ratio

15.35x

ROE

13.02%

ROCE

14.82%

Debt / Equity

0.18

Financial Performance

Particulars (₹ Cr)FY2023FY2024FY20259M FY2026
Revenue281.65304.62331.29275.57
EBITDA17.1724.8840.0737.55
PAT5.8212.2124.3827.03
Total Assets288.9250.54261.36327.6
Net Worth163.84176.29195.6223.05
Total Borrowings51.8736.8926.639.79

Valuation

Market Capitalisation

Pre-IPO₹553.13 Cr
Post-IPO₹553.13 Cr

P/E Ratio

Pre-IPO22.69x
Post-IPO15.35x

Promoter Holding

Pre-IPO89.41%
Post-IPO64.29%

Public Holding

Pre-IPO10.59%
Post-IPO35.71%

Lot Size & Allocation

Investment by Category

CategoryLot SizeMin InvestmentMax Investment
Retail (RII)333 shares₹14,985₹1,94,805
S-HNI14 × 333₹2,09,790₹9,89,010
B-HNI67 × 333₹10,03,995

Reservation / Allocation

CategoryAllocationCut-off
QIB (Qualified Institutional Buyers)50%Yes
NII (Non-Institutional Investors)15%No
RII (Retail Individual Investors)35%Yes

Registrar & Lead Managers

Registrar

KFin Technologies Ltd.

Lead Managers (2)

Cumulative Capital Pvt. Ltd.
Catalyst Capital Partners Pvt. Ltd.

Peer Comparison

CompanyListedMkt Cap (₹ Cr)EPS (₹)P/EROE %
Hexagon Nutrition IPO (this IPO)553.13₹2.9315.35x13.02%
Abbott India LtdYes
Nestle India LtdYes
Zydus Lifesciences LtdYes
GlaxoSmithKline Pharmaceuticals LtdYes

Data as of 31/3/2025

Frequently Asked Questions

8 questions about Hexagon Nutrition IPO IPO

Hexagon Nutrition IPO is a mainboard IPO of ₹138.87 crore, consisting entirely of an Offer for Sale (OFS) of 3.09 crore equity shares.

Important Dates

Issue Opens5 Jun 2026
Issue Closes9 Jun 2026
Allotment10 Jun 2026
Refund Initiation11 Jun 2026
Demat Credit11 Jun 2026
Listing Date12 Jun 2026

Live GMP

Grey Market Premium0.1
GMP %0.22%
View GMP History

Community Discussion

Ask questions and share your thoughts about this IPO

Post a message

0/2000

No account needed · posts are public

Be the first to ask or share about Hexagon Nutrition IPO

View full discussion page